糖尿病相关足病的中膜动脉钙化:当前肢体分期未描述的动脉壁维度
本文通过叙述性综述整合糖尿病相关足病中中膜动脉钙化(MAC)的证据,涉及动脉壁表型、对血流动力学评估的影响、预后关联及在肢体分期中的潜在作用。MAC 常见于糖尿病相关足病,尤其合并慢性肾脏病时,与内膜动脉粥样硬化不同;其与重大截肢、伤口愈合延迟和死亡 consistently 相关,但 WIfI 和 GLASS 均未描述动脉壁表型。作者建议在肢体分期系统修订中正式考虑 MAC,并评估其增量价值。
要点
- MAC 是糖尿病相关足病中常见的动脉壁表型,与内膜动脉粥样硬化不同,尤其合并慢性肾脏病时。
- MAC 与重大截肢、伤口愈合延迟和死亡相关,且调整 WIfI 分期后关联仍存在。
- WIfI 和 GLASS 未描述动脉壁表型,MAC 可作为 WIfI 缺血分级可靠性的限定因素。
核心结论
- MAC 预后证据的一致性和可重复性支持在即将修订的肢体分期系统和指南中正式考虑 MAC。
- 应同步进行增量价值分析,以指导任何修饰因素的形式,而非延迟评估。
- 一种具体途径是将 MAC 作为个体肢体 WIfI 缺血分级可靠性的限定因素。
研究设计与样本
- 叙述性综述,通过针对性数据库检索识别临床、影像、病理和机制文献。
- 参照 WIfI 分类和 GLASS 进行解读。
主要发现
- MAC 在糖尿病相关足病中常见,尤其合并慢性肾脏病时,是区别于内膜动脉粥样硬化的动脉壁表型。
- 踝臂指数升高不可解读,参考范围值不能排除外周动脉疾病。
- 在不同设计和定义的队列中,MAC 与重大截肢、伤口愈合延迟和死亡 consistently 相关,符合一项纳入 51 项钙化评分研究的系统综述。
- 五点足部评分已获外部验证,且调整 WIfI 分期后关联仍存在。
- 一个队列的模型比较提示增量信息,但超越既定分期的区分度、校准和重分类尚未报告。
关键数值与推荐
- WIfI 和 GLASS 均未描述动脉壁表型。
- 五点足部评分已获外部验证。
- 一项系统综述纳入 51 项钙化评分研究。
临床怎么用
- 临床应认识到 MAC 在糖尿病相关足病中的常见性,尤其合并慢性肾脏病时。
- 踝臂指数升高不可解读,参考范围值不能排除外周动脉疾病。
- MAC 可作为 WIfI 缺血分级可靠性的限定因素,辅助个体化评估。
局限性
- 叙述性综述,非系统评价。
- 超越既定分期的区分度、校准和重分类尚未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To synthesize the evidence on medial arterial calcification (MAC) in diabetes-related foot disease, addressing its arterial-wall phenotype, effects on haemodynamic assessment, prognostic associations, and its potential role in limb staging. METHODS: Narrative review of clinical, imaging, pathological and mechanistic literature identified through targeted database searches, interpreted with reference to the Wound, Ischaemia and foot Infection (WIfI) classification and the Global Limb Anatomic Staging System (GLASS). RESULTS: MAC is common in diabetes-related foot disease, particularly with chronic kidney disease, and is an arterial-wall phenotype distinct from intimal atherosclerosis. An elevated ankle-brachial index is uninterpretable, and a reference-range value does not exclude peripheral artery disease. Across cohorts of differing design and definition, MAC has been consistently associated with major amputation, delayed wound healing and mortality, in line with a systematic review of 51 calcification-scoring studies; the five-point pedal score has been externally validated, and associations persisted after adjustment for WIfI stage. Model comparison in one cohort suggests incremental information, but discrimination, calibration and reclassification beyond established staging have not been reported. Neither WIfI nor GLASS characterizes arterial-wall phenotype. CONCLUSIONS: The consistency and reproducibility of the prognostic evidence justify formal consideration of MAC in forthcoming revisions of limb-staging systems and guidelines. Incremental-value analyses should accompany that evaluation and inform the form of any modifier rather than delay it. One concrete route is to use MAC as a qualifier of the reliability of the WIfI ischaemia grade in the individual limb.
引用
- Galassi, Facchinetti, Ravini, et al. Medial Arterial Calcification in Diabetes-Related Foot Disease: An Arterial-Wall Dimension Uncharacterized in Current Limb Staging. Ann Vasc Surg. 2026. PMID: 42951195. doi:10.1016/j.avsg.2026.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。